[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Biologics, Wound Care Dressings), By Ulcer Type (Neuro-Ischemic, Ischemic, Neuropathic), And Segment Forecasts, 2022 - 2030

July 2022 | 125 pages | ID: EB03FED69169EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 3 Business Days

Europe Diabetic Foot Ulcer Treatment Market Growth & Trends

The Europe diabetic foot ulcer treatment market size is expected to reach USD 2.3 billion by 2030, registering a CAGR of 5.4%, according to a new report by Grand View Research, Inc.Diabetes is one of the major causes of amputation, blindness, stroke, end-stage renal failure, kidney failure, and heart attacks in this region. According to the International Diabetes Federation, ~66 million people were suffering from diabetes in Europe in 2017. The number is expected to increase to ~81 million by 2045. The mortality rate associated with DFU is ~5% in the first 12 months and increases up to 42% by the end of 5 years. Many adjuvant therapies, such as nonsurgical debridement agents, dressings & topical agents, oxygen therapies, negative pressure wound therapy, acellular bioproducts, human growth factors, energy-based therapies, and systemic therapies, are said to effectively improve and cure DFU.

Recent studies suggest that the inhibition of detrimental proteinase MMP-9 enzyme, allows the body to heal the wound at a quicker rate. The biologics segment held the largest revenue share in 2021 and is projected to expand further at the fastest CAGR during the forecast period. Biologics include growth factors, such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF), stem cells, and other anti-diabetic drugs. These agents help reduce hyperglycemia, increase oxygenation & circulation, and repair lost tissues. Therefore, they are increasingly being used for the management of wounds in different stages and are considered to be ideal for DFU treatment. Wound care dressings held the second-largest revenue share, followed by therapy devices and antibiotic medications, in 2021. Industry players are constantly developing new and improved products to ensure quicker healing time for DFU.

Europe Diabetic Foot Ulcer Treatment Market Report Highlights
  • The biologics treatment segment led the industry and accounted for the largest share in 2021 due to reduced wound healing time and increased platelet formation efficiency of biologics treatment
  • Germany accounted for the largest revenue share owing to the presence of the highest number of diabetic patients
  • Despite the COVID-19 pandemic, leading players reported an increase in demand for their wound management products due to the increased complications of diabetic patients suffering from COVID-19 infection
  • The market was said to increase at a steady rate in 2021, as COVID-19-treated patients witnessed a rise in sugar levels leading to the onset of diabetes
  • For instance, the overall proportion of patients with diabetes with COVID-19 ranged from 5% to 30% in Italy during 2020
  • Furthermore, Smith and Nephew reported the sales of their newly launched wound healing product, PICO 7, to cross the 1 million mark in 2020
  • Thus, the industry grew dramatically in 2020 and is estimated to stabilize during the forecast period
CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Research Methodology
  1.1.1 Information Procurement
1.2 Information Or Data Analysis
1.3 Research Scope and Assumptions
1.4 List Primary Sources

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE

3.1 Market Segmentation & Scope
3.2 Market Driver
  3.2.1 Increasing Number Of Diabetes Patients
  3.2.2 Rising Geriatric Population
  3.2.3 Increasing Government Initiative
3.3 Market Restraint
  3.3.1 High Cost Of Treatment
3.4 Europe Diabetic Foot Ulcer Treatment - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis - Porter’s Five Forces and Pestel Analysis
3.6 Cost Analysis
3.7 Europe Diabetic Foot Ulcer Treatment Market: Market Position Analysis, 2018

CHAPTER 4 DIABETIC FOOT ULCER TREATMENT MARKET: DISEASE PRIMER & EPIDEMIOLOGY

4.1 Diabetic Foot Ulcer Treatment Market: Disease Primer
  4.1.1 Definitions
    4.1.1.1 Infected Dfu And Non-Infected Dfu
4.2 Diabetic Foot Ulcer Treatment Market: Epidemiology
  4.2.1 Epidemiology: Current And Forecast For The Following Countries
    4.2.1.1 U.K.
    4.2.1.2 Germany
    4.2.1.3 France
    4.2.1.4 Italy
    4.2.1.5 Poland
    4.2.1.6 Spain

CHAPTER 5 DIABETIC FOOT ULCER TREATMENT MARKET: TREATMENT ESTIMATES & TREND ANALYSIS

5.1 Europe Diabetic Foot Ulcer Treatment Market: Treatment Movement Analysis
5.2 Wound Care Dressings
  5.2.1 Wound Care Dressings Market, 2018 - 2030 (USD Million)
  5.2.2 Alginate Dressings
    5.2.2.1 Alginate dressings market, 2018 - 2030 (USD Million)
  5.2.3 Hydrofiber Dressings
    5.2.3.1 Hydrofiber Dressings Market, 2018 - 2030 (USD Million)
  5.2.4 Foam Dressings
    5.2.4.1 Foam Dressings Market, 2018 - 2030 (USD Million)
  5.2.5 Film Dressings
    5.2.5.1 Film Dressings Market, 2018 - 2030 (USD Million)
  5.2.6 Hydrocolloid Dressings
    5.2.6.1 Hydrocolloid Dressings Market, 2018 - 2030 (USD Million)
  5.2.7 Surgical Dressings
    5.2.7.1 Surgical Dressings Market, 2018 - 2030 (USD Million)
  5.2.8 Hydrogel Dressings
    5.2.8.1 Hydrogel dressings market, 2018 - 2030 (USD Million)
5.3 Biologics
  5.3.1 Biologics Market, 2018 - 2030 (USD Million)
  5.3.2 Growth Factors
    5.3.2.1 Growth Factors Market, 2018 - 2030 (USD Million)
  5.3.3 Skin Grafts
    5.3.3.1 Skin grafts market, 2018 - 2030 (USD Million)
5.4 Therapy Devices
  5.4.1 Therapy Devices Market, 2018 - 2030 (USD Million)
  5.4.2 Negative Pressure Wound Therapy
    5.4.2.1 Negative Pressure Wound Therapy Market, 2018 - 2030 (USD Million)
  5.4.3 Ultrasound Therapy
    5.4.3.1 Ultrasound therapy market, 2018 - 2030 (USD Million)
5.5 Antibiotic Medication
  5.5.1 Antibiotic Medication Market, 2018 - 2030 (USD Million)
5.6 Others
  5.6.1 PhotoBiomodulation
    5.6.1.1 Photodynamic therapy
    5.6.1.2 Electric and magnetic fields
    5.6.1.3 Shock waves
    5.6.1.4 Nanotechnology
  5.6.2 Others Market, 2018 - 2030 (USD Million)

CHAPTER 6 DIABETIC FOOT ULCER TREATMENT MARKET: ULCER TYPE ESTIMATES & TREND ANALYSIS

6.1 Europe Diabetic Foot Ulcer Treatment Market: Ulcer Type Movement Analysis
6.2 Neuropathic Ulcers
  6.2.1 Neuropathic Ulcers Market, 2018 - 2030 (USD Million)
6.3 Ischemic Ulcers
  6.3.1 Ischemic Ulcers Market, 2018 - 2030 (USD Million)
6.4 Neuro-ischemic Ulcers
  6.4.1 Neuro-Ischemic Ulcers Market, 2018 - 2030 (USD Million)

CHAPTER 7 DIABETIC FOOT ULCER TREATMENT MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TREATMENT, ULCER TYPE

7.1 Diabetic Foot Ulcer Treatment Market Share by Region, 2018 & 2026
7.2 U.K.
  7.2.1 U.K. Market, 2018 - 2030 (USD Million)
7.3 Germany
  7.3.1 Germany Market, 2018 - 2030 (USD Million)
7.4 Italy
  7.4.1 Italy Market, 2018 - 2030 (USD Million)
7.5 France
  7.5.1 France Market, 2018 - 2030 (USD Million)
7.6 Spain
  7.6.1 Spain Market, 2018 - 2030 (USD Million)
7.7 Poland
  7.7.1 Poland Market, 2018 - 2030 (USD Million)

CHAPTER 8 COMPETITIVE LANDSCAPE

8.1 ConvaTec, Inc.
  8.1.1 Company Overview
  8.1.2 Financial Performance
  8.1.3 Product Benchmarking
  8.1.1 Recent Developments
8.2 Acelity L.P. Inc.
  8.2.1 Company Overview
  8.2.2 Financial Performance
  8.2.3 Product Benchmarking
  8.2.4 Recent Developments
8.3 3M Healthcare
  8.3.1 Company Overview
  8.3.2 Financial Performance
  8.3.3 Product Benchmarking
  8.3.4 Recent Developments
8.4 Coloplast Corp
  8.4.1 Company Overview
  8.4.2 Financial Performance
  8.4.3 Product Benchmarking
  8.4.4 Recent Developments
8.5 Smith & Nephew Plc
  8.5.1 Company Overview
  8.5.2 Financial Performance
  8.5.3 Product Benchmarking
  8.5.1 Recent Developments
8.6 B Braun Melsungen AG
  8.6.1 Company Overview
  8.6.2 Financial Performance
  8.6.3 Product Benchmarking
  8.6.4 Recent Developments
8.7 Medline Industries, Inc.
  8.7.1 Company Overview
  8.7.2 Product Benchmarking
  8.7.3 Recent Development
8.8 Organogenesis, Inc.
  8.8.1 Company Overview
  8.8.2 Financial Performance
  8.8.3 Product Benchmarking
  8.8.4 Recent Development
8.9 Molnlycke Health Care AB
  8.9.1 Company Overview
  8.9.2 Financial Performance
  8.9.3 Product Benchmarking
  8.9.4 Recent Development
8.10 Medtronic
  8.10.1 Company Overview
  8.10.2 Financial Performance
  8.10.3 Product Benchmarking
  8.10.4 Recent Developments
LIST OF TABLES

Table 1 List of Abbreviations
Table 2 Europe diabetic foot ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
Table 3 Europe diabetic foot ulcer treatment market, by ulcer type, 2018 - 2030 (USD Million)
Table 4 Europe diabetic foot ulcer treatment market, by region, 2018 - 2030 (USD Million)
LIST OF FIGURES

Fig. 1 Europe diabetic foot ulcer treatment market segmentation
Fig. 2 Europe diabetic foot ulcer treatment market driver impact
Fig. 3 Europe diabetic foot ulcer treatment market restraint impact
Fig. 4 Europe diabetic foot ulcer treatment market: SWOT analysis, by factor (political & legal, economic and technological)
Fig. 5 Europe diabetic foot ulcer treatment market: SWOT analysis, by factor (political & legal, economic and technological)
Fig. 6 Europe Diabetic foot ulcer treatment market: Market position analysis, 2018
Fig. 7 Europe diabetic foot ulcer treatment market: Treatment movement analysis
Fig. 8 Wound care dressings market, 2018 - 2030 (USD Million)
Fig. 9 Alginate dressings market, 2018 - 2030 (USD Million)
Fig. 10 Hydrofiber dressings market, 2018 - 2030 (USD Million)
Fig. 11 Foam dressings market, 2018 - 2030 (USD Million)
Fig. 12 Film dressings market, 2018 - 2030 (USD Million)
Fig. 13 Hydrocolloid dressings market, 2018 - 2030 (USD Million)
Fig. 14 Surgical dressings market, 2018 - 2030 (USD Million)
Fig. 15 Hydrogel dressings market, 2018 - 2030 (USD Million)
Fig. 16 Biologics market, 2018 - 2030 (USD Million)
Fig. 17 Growth factors market, 2018 - 2030 (USD Million)
Fig. 18 Skin grafts market, 2018 - 2030 (USD Million)
Fig. 19 Therapy devices market, 2018 - 2030 (USD Million)
Fig. 20 Negative pressure wound therapy market, 2018 - 2030 (USD Million)
Fig. 21 Ultrasound therapy market, 2018 - 2030 (USD Million)
Fig. 22 Antibiotic medication market, 2018 - 2030 (USD Million)
Fig. 23 Others market, 2018 - 2030 (USD Million)
Fig. 24 Europe diabetic foot ulcer treatment market: Ulcer type movement analysis
Fig. 25 Neuropathic ulcers market, 2018 - 2030 (USD Million)
Fig. 26 Ischemic ulcers market, 2018 - 2030 (USD Million)
Fig. 27 Neuro-ischemic ulcers market, 2018 - 2030 (USD Million)
Fig. 28 Diabetic foot ulcer treatment market share by region, 2018 & 2026
Fig. 29 U.K. market, 2018 - 2030 (USD Million)
Fig. 30 Germany market, 2018 - 2030 (USD Million)
Fig. 31 Italy market, 2018 - 2030 (USD Million)
Fig. 32 France market, 2018 - 2030 (USD Million)
Fig. 33 Spain market, 2018 - 2030 (USD Million)
Fig. 34 Poland market, 2018 - 2030 (USD Million)


More Publications